Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.7600 (-7.84%) ($5.4200 - $5.9500) on Thu. Jul. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.75% (three month average) | RSI | 44 | Latest Price | $5.7600(-7.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.5% a day on average for past five trading days. | Weekly Trend | ANPC declines -5.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(12%) LIT(9%) PCY(9%) OIH(8%) FXI(7%) | Factors Impacting ANPC price | ANPC will decline at least -2.375% in a week (0% probabilities). SHY(-18%) IBB(-9%) XBI(-8%) XLU(-5%) XLP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.375% (StdDev 4.75%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
Resistance Level | $6.45 | 5 Day Moving Average | $6.21(-7.25%) | 10 Day Moving Average | $5.95(-3.19%) | 20 Day Moving Average | $6.45(-10.7%) | To recent high | -32.2% | To recent low | 13.2% | Market Cap | $49m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |